EULAR and ACR responses at 3, 12 and 24 months
| 3 Months | 12 Months | 24 Months | 3 Months | 12 Months | 24 Months | |
|---|---|---|---|---|---|---|
| No in group | 142 | 114 | 110 | 147 | 147 | 147 |
| EULAR good response | 95.1% | 76.3% | 85.5% | 91.8% (135) | 59.2% (87) | 63.9% (94) |
| EULAR good or moderate response | 95.2% | 92.1% | 97.3% | 98.6% (140) | 71.4% (105) | 72.7% (107) |
| ACR20 | 89.6% | 83.9% | 86.4% | 87.8% (129) | 63.9% (94) | 60.5% (89) |
| ACR50 | 73.6% | 70.5% | 81.6% | 72.1% (106) | 53.7% (79) | 57.1% (84) |
| ACR70 | 35.4% | 41.1% | 47.6% | 34.7% (51) | 31.3% (46) | 33.3% (49) |
Left section: based on available follow-up data; right section: patients with missing data imputed as non-responders.
ACR, American College of Rheumatology; EULAR, European League Against Rheumatism.